Portfolio of Big Pharma and Biotech Cancer Immunotherapy Stocks
Here are 10 big pharma and big biotech cancer immunotherapy stocks.
10 Big Pharma and Biotech Cancer Immunotherapy Stocks | ||
---|---|---|
Stock & Price Chart | Symbol | Recent Prices & |
Amgen | AMGN | |
AstraZeneca | AZN | |
Bristol-Myers Squibb | BMY | |
Celgene | CELG | |
Gilead Sciences | GILD | |
Incyte Corporation | INCY | |
Merck | MRK | |
Nektar Therapeutics | NKTR | |
Novartis | NVS | |
Pfizer | PFE | |
Price data from Quandl as of most recent close. |
To inspect the performance of the Big Pharma and Biotech Cancer Immunotherapy Stocks
portfolio, see the chart of portfolio below. Portfolio values are computed using monthly closes for stocks from Quandl.
The current value of a $10,000 investment is $79,240. The percent return is 692.40%. The annualized return is 23.00%.